JCCC 2012 Issue 7
Table of Contents
Gastrointestinal Diseases
MD, FRCPC, CSPQ
With this special issue of the Journal of Current Clinical Care we aim to provide community healthcare professionals with practical clinical insight and support in managing patients with ulcerative colitis.
Gastrointestinal Diseases
MD, FRCPC, CSPQ
With this special issue of the Journal of Current Clinical Care we aim to provide community healthcare professionals with practical clinical insight and support in managing patients with ulcerative colitis
Gastrointestinal Diseases
MD
Although medical therapy for ulcerative colitis is usually effective at inducing clinical remission, numerous studies have shown that patients in clinical remission may have ongoing and varying degrees of mucosal inflammation.
Gastrointestinal Diseases
MD, MS, FRCPC
A 28-year-old male presented to our office for a consultation about his bloody bowel movements. Colonoscopy revealed moderately active left-sided ulcerative colitis extending from the anal verge up to the mid-descending colon.
Gastrointestinal Diseases
MD, PhD
5-Aminosalicylates (5-ASAs) are considered first-line therapy for mild to moderate ulcerative colitis because of their proven effectiveness and safety profile, even in pregnancy.
Gastrointestinal Diseases
MD
Informed patients are one of the most important assets available in the management of patients with ulcerative colitis.
Gastrointestinal Diseases
From time-to-time we select a topic and present the information and facts in an exciting and visually informative format.